Validation of endothelin-1 as a predictor of adverse prognosis in coronary artery disease patients with impaired kidney function with or without diabetes

31 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by